Genencor International, Inc.
Division Headquarters
925 Page Mill Road
Palo Alto
California
94304
United States
Tel: 650-846-7500
Fax: 650-845-6500
Website: http://www.genencor.com/
About Genencor International, Inc.
Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance and develops novel products, for a spectrum of industries. As part of a large global organization, Genencor’s manufacturing and distribution network spans more than 40 countries.Industries Genencor serves include:
• Textiles • Fabric & Household Care • Biofuels – current and cellulosic ethanol • Sweetener production • Biodefense • Biochemicals • Industrial processing • Animal Nutrition (Danisco-branded) • Food & Beverage (Danisco-branded)
In collaboration with customers, technology leaders and other stakeholders, Genencor supplies competitive, biobased solutions. These innovations create value throughout the supply chain, from raw material to finished product, while working toward a low-carbon economy.
Genencor core competencies:
• We design and operate cell factories • We rapidly create engineered proteins that accomplish what was previously considered impossible, delivering significant value to our most important customers • We engineer the metabolic pathways of microorganisms to produce enzymes, proteins and other biomolecules at industrial scale and economics
Genencor led the way in manufacturing enzymes on a large-scale and applying protein engineering to optimize customer applications. Since then Genencor has launched many breakthrough innovations, from new polymer platforms to advanced biofuel and biochemical solutions. In 2008 we established the joint venture DuPont Danisco Cellulosic Ethanol LLC, and also announced a research collaboration with Goodyear Tire & Rubber Company to develop BioIsoprene?, used to make synthetic rubber for tires.
The division employs about 1400 people. U.S. headquarters are located in Rochester, NY, and Palo Alto, California, where we have our R&D facilities.
For more information, visit www.genencor.com http://www.genencor.com/ or call 1-800-847-5311.
16 articles about Genencor International, Inc.
-
Chris Lehman Joins Avellino Labs As Chief Financial Officer
1/14/2020
Avellino Labs, global biotechnology and precision medicine innovators, announced that Chris Lehman has joined the company as Chief Financial Officer.
-
Genencor International, Inc. Named One of America’s Best Places to Work
10/18/2011
-
Verdezyne Signs Second Project with Genencor International, Inc.
1/14/2009
-
CODA Genomics, Inc. Signs Collaboration Agreement With Genencor International, Inc.
10/14/2008
-
Protein Polymer Technologies Announces Signing Extended Amendment With Genencor International, Inc.
10/19/2006
-
Genencor International, Inc. Launches Improved Acid Fungal Protease For Use In The Ethanol Industry
6/19/2006
-
Ethanol from Paper Pulp: Genencor International, Inc. Announces French Government Funded Project
5/1/2006
-
Genencor International, Inc. To Provide i-mune(R) Assay Evaluation Services To BioMarin Pharmaceutical Inc.
4/28/2006
-
Genencor International, Inc. Launches Revolutionary Enzyme Technology For Prion Decontamination
3/26/2006
-
Trade Secret Lawsuit Against Genencor International, Inc. Dismissed
3/8/2006
-
Genencor International, Inc. Heralds Pres. Bush's Call To Move Beyond A Petroleum Based Economy
2/1/2006
-
Cambridge Antibody Technology Group PLC Acquires Oncology Product Candidates From Genencor International, Inc.
11/1/2005
-
Genencor International, Inc. Awarded $2 Million Contract For Biodefense Work
10/31/2005
-
Genencor Launches Hazardous Chemical Decontamination Enzymes For First Responders
11/11/2004
-
Biotech Bay's First Biotech House
7/26/2004
-
Genencor International, Inc. To Present At The 22nd Annual JPMorgan Healthcare Conference
1/8/2004